Extended Data Table 4 Clinical scenario analysis of cost-effectiveness under an alternative standard, fixed-course, static treatment

From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

  1. Abbreviations: ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life years; CCRT, concurrent chemoradiotherapy; GP, gemcitabine plus cisplatin.
Back to article page